Portfolio Company · Operating Co.
Company Snapshot
Twenty20 is a portfolio company held by Canaan Partners. Profile compiled from public sources; submit updates to extend the public record.
Ownership Context
Twenty20 is a current portfolio company of Canaan Partners. Public coverage of this company is grouped under its parent firm's profile.
Sources
https://canaan.com/companiesThis profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Twenty20 and does not provide investment advice.
Other portfolio companies of Canaan Partners
Abyrx
Aceiss
Acesion Pharma ApS
Actio Biosciences, Inc.
ACTIVE Network
ActualyzeAI, Inc.
Advanced BioHealing
Aer Therapeutics, Inc.
See the full Canaan Partners portfolio.